Lipitor Class Action Suit Alleges Improper Promotion To Women And Elderly
This article was originally published in The Pink Sheet Daily
Complaint cites Pfizer's promotion to physicians, direct-to-consumer advertising and public relations campaigns.
You may also be interested in...
Atorvastatin’s expanded label also includes an indication for reducing the risk of stroke in patients without evidence of heart disease but with multiple risk factors other than diabetes.
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.
The U.K.’s Health and Social Care Bill was introduced into Parliament on Jan. 19, offering a new commercial landscape best navigated by pharma through bolstered relationships with general practitioners.